EP1325120A4 - Acides nucleiques et polypeptides - Google Patents

Acides nucleiques et polypeptides

Info

Publication number
EP1325120A4
EP1325120A4 EP01977088A EP01977088A EP1325120A4 EP 1325120 A4 EP1325120 A4 EP 1325120A4 EP 01977088 A EP01977088 A EP 01977088A EP 01977088 A EP01977088 A EP 01977088A EP 1325120 A4 EP1325120 A4 EP 1325120A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
new nucleic
new
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01977088A
Other languages
German (de)
English (en)
Other versions
EP1325120A2 (fr
Inventor
Y Tom Tang
Chenghua Liu
Ping Zhou
Vinod Asundi
Jie Zhang
Qing A Zhao
Feiyan Ren
Aidong J Xue
Yonghong Yang
Tom Wehrman
Radoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1325120A2 publication Critical patent/EP1325120A2/fr
Publication of EP1325120A4 publication Critical patent/EP1325120A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP01977088A 2000-10-12 2001-10-11 Acides nucleiques et polypeptides Withdrawn EP1325120A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68752700A 2000-10-12 2000-10-12
US687527 2000-10-12
PCT/US2001/027760 WO2002031111A2 (fr) 2000-10-12 2001-10-11 Acides nucleiques et polypeptides

Publications (2)

Publication Number Publication Date
EP1325120A2 EP1325120A2 (fr) 2003-07-09
EP1325120A4 true EP1325120A4 (fr) 2005-05-25

Family

ID=24760764

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01977088A Withdrawn EP1325120A4 (fr) 2000-10-12 2001-10-11 Acides nucleiques et polypeptides

Country Status (4)

Country Link
EP (1) EP1325120A4 (fr)
AU (1) AU2001296235A1 (fr)
CA (1) CA2425827A1 (fr)
WO (1) WO2002031111A2 (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A3 (fr) * 1999-07-29 2004-04-21 Research Association for Biotechnology Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
EP2067862A1 (fr) 1999-11-05 2009-06-10 The General Hospital Corporation Molécules d'acide nucléique d'obstruction, polypeptides, et diagnostic et procédés thérapeutiques
US8642284B1 (en) 1999-12-15 2014-02-04 Massachusetts Institute Of Technology Methods for identifying agents that alter NAD-dependent deacetylation activity of a SIR2 protein
US7452664B2 (en) 1999-12-15 2008-11-18 Massachusetts Institute Of Technology Methods for identifying agents which alter histone protein acetylation
EP1250434B1 (fr) 2000-01-26 2008-04-16 Agensys, Inc. 84p2a9: proteine specifique de la prostate et du testicule fortement exprimee dans le cancer de la prostate
WO2002000939A2 (fr) 2000-06-28 2002-01-03 Diadexus, Inc. Procede de diagnostic, de surveillance, de determination du stade, d'imagerie et de traitement du cancer du colon
JP2002034565A (ja) * 2000-07-19 2002-02-05 Japan Science & Technology Corp 細菌ｄｎａを特異的に認識する受容体タンパク質
JP2004518413A (ja) * 2000-10-12 2004-06-24 エクセリクシス・インコーポレイテッド ヒトｅｃｔ２と使用方法
AU2002210961A1 (en) * 2000-10-30 2002-05-15 Takeda Chemical Industries Ltd. Novel gene overexpressed in heart and skeletal muscle and use tehreof
US7572575B2 (en) 2000-12-13 2009-08-11 Massachusetts Institute Of Technology SIR2 activity
MXPA03005436A (es) 2000-12-20 2004-05-05 Bristol Myers Squibb Co Polinucleotidos novedosos que codifican fosfastasas humanas.
EP1383797A2 (fr) * 2001-02-07 2004-01-28 Universiteit Maastricht Marqueurs de plaques d'atherosclerose instables
CA2443088C (fr) * 2001-04-10 2013-02-19 Agensys, Inc. Acide nucleique et proteine correspondante appele 121p2a3 utile pour le traitement et la detection des cancers
US7736654B2 (en) 2001-04-10 2010-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
CA2449275A1 (fr) * 2001-06-05 2002-12-12 Exelixis, Inc. Dgk en tant que modulateurs du mecanisme d'action de p53 et procedes d'utilisation
WO2003004989A2 (fr) 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, trousses, et procedes d'identification, d'evaluation, de prevention, et de therapie pour le cancer du sein
JP2003024080A (ja) * 2001-07-19 2003-01-28 Univ Tokyo ｐ５３依存性アポトーシス誘導タンパク質、およびアポトーシス調節剤のスクリーニング方法
AU2003281314A1 (en) * 2002-07-09 2004-01-23 Takeda Pharmaceutical Company Limited Nove protein and use thereof
JP4301541B2 (ja) * 2002-09-05 2009-07-22 独立行政法人科学技術振興機構 Ｓｍｇ−１結合タンパク質及びその活性を制御する物質のスクリーニング方法
EP2116551A1 (fr) * 2002-09-11 2009-11-11 Genentech, Inc. Compositions et procédés pour le traitement de maladies liées au système immunitaire
WO2004042386A2 (fr) * 2002-11-08 2004-05-21 Bayer Healthcare Ag Moyens diagnostiques et therapeutiques destines a des maladies associees a la phosphodiesterase 11a3 (pde11a3) humaine
AU2003901055A0 (en) * 2003-02-17 2003-03-20 Nathan E Hall Methods for inhibiting signal transduction
EP1627051A4 (fr) * 2003-05-07 2006-09-06 Univ Massachusetts Regulation de l'expression d'acheron
US20050026194A1 (en) * 2003-06-20 2005-02-03 Tularik Inc. Gene amplification and overexpression in cancer
WO2005014817A2 (fr) * 2003-08-07 2005-02-17 Compugen Ltd. Homologues de type chordine
WO2005040205A1 (fr) * 2003-10-28 2005-05-06 Protemix Discovery Limited Peptides avec action contre l'obesite et autre utilisations apparentees
US7638490B2 (en) 2004-02-09 2009-12-29 Eisai R&D Managment Co., Ltd. Methods of affecting feeding and weight in mammals by administration of relaxin-3
JP2007522791A (ja) * 2004-02-24 2007-08-16 オンコセラピー・サイエンス株式会社 結腸直腸癌を診断する方法
WO2005118811A1 (fr) * 2004-06-02 2005-12-15 Tss Biotech Inc. Nouveau polypeptide utile pour diagnostiquer et pour traiter le cancer
JP4468989B2 (ja) 2004-08-16 2010-05-26 クアーク・ファーマスーティカルス、インコーポレイテッド Ｒｔｐ８０１阻害剤の治療への使用
US7531634B2 (en) * 2004-12-03 2009-05-12 University Of Pittsburgh Bladder matrix protein peptides and methods of detection of bladder cancer
EP1856278A2 (fr) * 2005-02-10 2007-11-21 Oncotherapy Science, Inc. Methode de diagnostic du cancer de la vessie
US20070099830A1 (en) 2005-04-21 2007-05-03 Massachusetts Institute Of Technology Sirt4 activities
US20090297508A1 (en) * 2005-04-25 2009-12-03 University Of Yamanashi Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction
NL2000439C2 (nl) 2006-01-20 2009-03-16 Quark Biotech Therapeutische toepassingen van inhibitoren van RTP801.
GB2450840B (en) 2006-05-11 2010-12-29 Quark Pharmaceuticals Inc Screening Systems Utilizing RTP801
WO2007141796A2 (fr) 2006-06-09 2007-12-13 Quark Pharmaceuticals, Inc. Utilisations thérapeutiques d'inhibiteurs de rtp801l
DK2091965T3 (da) 2006-10-17 2013-08-05 Oncotherapy Science Inc Peptidvacciner mod cancere, der udtrykker MPHOSPH1- eller DEPDC1-polypeptider
US7872119B2 (en) 2007-02-26 2011-01-18 Quark Pharmaceuticals, Inc. Inhibitors of RTP801 and their use in disease treatment
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
WO2010014572A2 (fr) * 2008-07-28 2010-02-04 Idera Pharmaceuticals, Inc. Modulation de l’expression du récepteur de type toll 9 par des oligonucléotides antisens
JP5640263B2 (ja) 2008-08-28 2014-12-17 オンコセラピー・サイエンス株式会社 Ｄｅｐｄｃ１ポリペプチドを使用した膀胱癌の治療または予防のための方法
RU2733985C2 (ru) 2009-03-18 2020-10-09 Онкотерапи Сайенс, Инк. Пептиды neil3 и включающие их вакцины
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
GB201009654D0 (en) * 2010-06-09 2010-07-21 Cancer Res Technology Nucleic acid methyltransferase
US8962587B2 (en) * 2011-08-31 2015-02-24 Taipei Veterans General Hospital Gene delivery of OCT4 and SirT1 and pharmaceutical compositions thereof
WO2016086088A2 (fr) 2014-11-25 2016-06-02 Northwestern University Cicatrisation par surexpression de sirt1
TWI769984B (zh) 2015-08-12 2022-07-11 日商腫瘤療法 科學股份有限公司 來自ｄｅｐｄｃ１之胜肽及含此之疫苗
WO2019178364A2 (fr) * 2018-03-14 2019-09-19 Elstar Therapeutics, Inc. Molécules multifonctionnelles et utilisations associées
WO2025053123A1 (fr) * 2023-09-04 2025-03-13 国立研究開発法人理化学研究所 Procédé d'amélioration de la fonction mitochondriale

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018022A1 (fr) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 52 proteines humaines secretees
WO2001077137A1 (fr) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Proteines de fusion d'albumine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018022A1 (fr) * 1999-09-03 2001-03-15 Human Genome Sciences, Inc. 52 proteines humaines secretees
WO2001077137A1 (fr) * 2000-04-12 2001-10-18 Human Genome Sciences, Inc. Proteines de fusion d'albumine

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 October 1998 (1998-10-01), XP002307625, retrieved from EBI Database accession no. AI148629 *
DATABASE EMBL [online] 22 May 2001 (2001-05-22), NI ET AL., XP002307627, retrieved from EBI Database accession no. AAF91870 *
DATABASE EMBL [online] 3 March 2000 (2000-03-03), ZHANG ET AL., XP002307624, retrieved from EBI Database accession no. AF151068 *
DATABASE GENSEQ [online] 27 August 2002 (2002-08-27), ROSEN ET AL., XP002307628, retrieved from EBI Database accession no. ABG65339 *
DATABASE GENSEQ 22 May 2001 (2001-05-22), NI ET AL., XP002307626, retrieved from EBI Database accession no. AAB87354 *
See also references of WO0231111A3 *
ZHANG ET AL: "Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoetic stem/progenitor cells", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 10, no. 10, October 2000 (2000-10-01), pages 1546 - 1560, XP002215896, ISSN: 1088-9051 *

Also Published As

Publication number Publication date
AU2001296235A1 (en) 2002-04-22
CA2425827A1 (fr) 2002-04-18
WO2002031111A2 (fr) 2002-04-18
EP1325120A2 (fr) 2003-07-09
WO2002031111A3 (fr) 2002-10-17

Similar Documents

Publication Publication Date Title
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1341804A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1504099A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1432800A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1242443A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1556490A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1368475A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
ATE554171T1 (de) Rezeptor-nukleinsäuren und -polypeptide
AU2001234944A8 (en) Novel nucleic acids and polypeptides
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
EP1483386A4 (fr) Nouveaux acides nucleiques et polypeptides secretes
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1282635A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1268762A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1131350A4 (fr) Acides nucleiques et polypeptides et utilisations correspondantes
EP1370675A4 (fr) Nouveaux acides nucleiques et polypeptides
ATE328003T1 (de) Chimäre nukleinsäuren und polypeptide aus lyssavirus
AU7005801A (en) Gp354 nucleic acids and polypeptides
DE60217711D1 (de) Ptp10d nukleinsäuren und peptide in der regulation von energie-homeostase
AU7298201A (en) Gp286 nucleic acids and polypeptides
ATE270675T1 (de) Pro243 polypeptide und dafür kodierende nukleinsäuren
DE60044849D1 (de) Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
DE60043951D1 (de) Ausgeschiedene Polypeptide und Transmembranpolypeptide und dafür kodierende Nukleinsäuren
ATE459645T1 (de) Ausgeschiedene polypeptide und transmembranpolypeptide und dafür kodierende nukleinsäuren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030415

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/47 B

Ipc: 7C 12N 15/12 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050406

17Q First examination report despatched

Effective date: 20050524

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050928